Literature DB >> 10623767

Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells.

H M Spiegel1, G S Ogg, E DeFalcon, M E Sheehy, S Monard, P A Haslett, G Gillespie, S M Donahoe, H Pollack, W Borkowsky, A J McMichael, D F Nixon.   

Abstract

CD4(+) T cells are thought to be critical in the maintenance of virus-specific CD8(+) cytotoxic T-cell (CTL) responses. In human immunodeficiency virus type 1 (HIV-1) infection, a selective decline in HIV-1-specific CTL as the CD4(+) T-cell count decreases has been reported. Using HLA-peptide tetrameric complexes, we show the presence at high frequency of HIV-1- and cytomegalovirus-specific CD8(+) T cells when the peripheral CD4(+) T-cell count was low or zero in three HIV-1-infected patients. No direct virus-specific CD8(+)-mediated effector activity was seen in these subjects, suggesting antigen unresponsiveness, although tetramer-sorted cells could be expanded in vitro in the presence of interleukin-2 into responsive effector cells. Thus, virus-specific CD8(+) T cells can be maintained in the peripheral circulation at high frequency in the absence of circulating peripheral CD4(+) T cells, but these cells may lack direct effector activity. Strategies designed to overcome this antigen unresponsiveness may be of value in therapies for the treatment of AIDS.

Entities:  

Mesh:

Year:  2000        PMID: 10623767      PMCID: PMC111625          DOI: 10.1128/jvi.74.2.1018-1022.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons.

Authors:  A M Geretti; M E Dings; C A van Els; C A van Baalen; F J Wijnholds; J C Borleffs; A D Osterhaus
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

2.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

Authors:  M R Wills; A J Carmichael; K Mynard; X Jin; M P Weekes; B Plachter; J G Sissons
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection.

Authors:  M G Von Herrath; B Coon; M B Oldstone
Journal:  Virology       Date:  1997-03-17       Impact factor: 3.616

4.  Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.

Authors:  M J Kersten; M R Klein; A M Holwerda; F Miedema; M H van Oers
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.

Authors:  R D Cardin; J W Brooks; S R Sarawar; P C Doherty
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

6.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

Authors:  Y Cao; L Qin; L Zhang; J Safrit; D D Ho
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

7.  Phenotypic analysis of antigen-specific T lymphocytes.

Authors:  J D Altman; P A Moss; P J Goulder; D H Barouch; M G McHeyzer-Williams; J I Bell; A J McMichael; M M Davis
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

8.  CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.

Authors:  P Hermann; C Van-Kooten; C Gaillard; J Banchereau; D Blanchard
Journal:  Eur J Immunol       Date:  1995-10       Impact factor: 5.532

9.  Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS.

Authors:  Y Rivière; M B McChesney; F Porrot; F Tanneau-Salvadori; P Sansonetti; O Lopez; G Pialoux; V Feuillie; M Mollereau; S Chamaret
Journal:  AIDS Res Hum Retroviruses       Date:  1995-08       Impact factor: 2.205

10.  Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics.

Authors:  M R Klein; C A van Baalen; A M Holwerda; S R Kerkhof Garde; R J Bende; I P Keet; J K Eeftinck-Schattenkerk; A D Osterhaus; H Schuitemaker; F Miedema
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  13 in total

1.  HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death.

Authors:  S J Brodie; B K Patterson; D A Lewinsohn; K Diem; D Spach; P D Greenberg; S R Riddell; L Corey
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus.

Authors:  Aaruni Khanolkar; Michael J Fuller; Allan J Zajac
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.

Authors:  Annetie Oxenius; Andrew K Sewell; Sara J Dawson; Huldrych F Günthard; Marek Fischer; Geraldine M Gillespie; Sarah L Rowland-Jones; Catherine Fagard; Bernard Hirschel; Rodney E Phillips; David A Price
Journal:  J Clin Immunol       Date:  2002-11       Impact factor: 8.317

4.  A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.

Authors:  P A Goepfert; A Bansal; B H Edwards; G D Ritter; I Tellez; S A McPherson; S Sabbaj; M J Mulligan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  The functional CD8 T cell response to HIV becomes type-specific in progressive disease.

Authors:  Sang Kyung Lee; Zhan Xu; Judy Lieberman; Premlata Shankar
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining.

Authors:  Lucas Gonzalez-Nieto; Aline Domingues; Michael Ricciardi; Martin J Gutman; Helen S Maxwell; Nuria Pedreño-Lopez; Varian Bailey; Diogo M Magnani; Mauricio A Martins
Journal:  J Vis Exp       Date:  2016-12-23       Impact factor: 1.355

7.  Simian immunodeficiency virus (SIV) infection of a rhesus macaque induces SIV-specific CD8(+) T cells with a defect in effector function that is reversible on extended interleukin-2 incubation.

Authors:  Y Xiong; M A Luscher; J D Altman; M Hulsey; H L Robinson; M Ostrowski; B H Barber; K S MacDonald
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.

Authors:  V Novitsky; N Rybak; M F McLane; P Gilbert; P Chigwedere; I Klein; S Gaolekwe; S Y Chang; T Peter; I Thior; T Ndung'u; F Vannberg; B T Foley; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 9.  Shaping successful and unsuccessful CD8 T cell responses following infection.

Authors:  Maureen A Cox; Allan J Zajac
Journal:  J Biomed Biotechnol       Date:  2010-03-31

10.  Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children.

Authors:  M E Feeney; K A Roosevelt; Y Tang; K J Pfafferott; K McIntosh; S K Burchett; C Mao; B D Walker; P J R Goulder
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.